Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 41 Metastatic Castration-resistant Prostate Cancer 4 Prostatic Diseases 3 Kidney Neoplasms 3 Urogenital Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 2 Neoplasms by Site 2 Neoplasms 2 Genital Neoplasms, Male 2 Carcinoma, Renal Cell 2 Thrombocytopenia 1 Renal Insufficiency 1 Prostate Cancer Metastatic 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasm Metastasis 1 Metastatic Hormone Naive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Metastatic Castration Resistant Prostate Cancer 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Male Urogenital Diseases 1 Liver Neoplasms 1 High-Risk Localized Prostate Cancer 1 Glioma 1 Glioblastoma 1 Genital Diseases, Male 1 Disease 1 Cytopenia 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Blood Specimen Collection 6 Prednisone 5 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Exercise 3 Biopsy 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Educational Status 2 Doxorubicin 2 Cytarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Pluvicto × Clear all

NCT07054346 2026-04-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡